Pfizer Inc
NYSE: PFE
▲
37.53
+0.01
+0.03%
1 Day
-
Open
37.50
-
Previous Close
37.52
-
Volume (Avg)
14.46M (14.53M)
-
Day's Range
37.22-37.59
-
52Wk Range
32.32-39.43
-
Market Cap.
219.53B
-
Dividend Rate (Yield)
1.36 (3.62%)
-
Beta
0.93
-
Shares Outstanding
5.85B
-
P/E Ratio (EPS)
10.43 (3.60)
Top Stories
-
Astellas, Pfizer (PFE) Gain FDA Approval for XTANDI to Treat Prostate Cancer
StreetInsider 2 days agoNews and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. Astellas Pharma Inc. and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental ...
-
Did Pfizer Blink, And What Will Pharma Do Now?
Forbes -
Pfizer Is Not An All-Powerful Price-Hiker
Seeking Alpha -
Pfizer boss humbled after ‘man to man’ talk with Donald Trump
Financial Times -
Trump Protection For Pfizer
Seeking Alpha 5 days agoPresident Trump took to Twitter Monday to threaten Pfizer with an unspecified response for raising drug prices. In light of Trump's threat, I present two ways Pfizer shareholders can limit their downside risk. I also note an implication of the cost of one ...
-
Pfizer reorganizes to handle aging consumers and patents
Joplin Globe -
Trump gulled by pharma Pfizer, but calls it a 'win' anyway
Daily Kos -
Shearman Works On $203M Alexandria-Pfizer Sale-Leaseback
Law360 -
Generic Viagra floods the market. Here’s how Pfizer is reacting
Marketplace -
University of Michigan opens $160M test center in old Pfizer buildings
MLive -
Pfizer Inc to split company into three units
uk.investing.com -
Trump’s tweets prompt Pfizer to postpone drug price hikes
C&EN -
Pfizer to reorganize into 3 business divisions
Drug Store News -
Pfizer postpones drug price hikes after Trump warns
Canindia.com -
The Drug Pricing Dilemma, Pfizer, And President Trump
Life Science Leader 2 days ago -
How Pfizer-Trump Game Of Chicken Could Play Out For Drug Prices
Investor's Business Daily -
Pfizer Separates Consumer Health Unit In Business Rejig
esmmagazine.com -
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More
Xconomy
